Drug Profile
AWD 47208
Latest Information Update: 13 Mar 2002
Price :
$50
*
At a glance
- Originator elbion
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy
Most Recent Events
- 13 Mar 2002 Discontinued - Preclinical for Epilepsy in Germany (unspecified route)
- 18 Jul 2001 No-Development-Reported for Epilepsy in Germany (Unknown route)
- 05 Aug 1998 Preclinical development for Epilepsy in Germany (Unknown route)